NIVF vs PIII

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

NIVF

33.6
AI Score
VS
PIII Wins

PIII

40.4
AI Score

Investment Advisor Scores

NIVF

34score
Recommendation
AVOID NEW MONEY

PIII

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF PIII Winner
Forward P/E 0.0015 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -4.7% 8.6% PIII
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 33.6/100 40.4/100 PIII
Profit Margin 24.2% -6.6% NIVF
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD PIII

Relative Price Performance (Last 90 Days)

NIVF 1M: +19.9% · 3M: -46.0% PIII 1M: -23.9% · 3M: -71.1%

Current Technical Phase

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.1 · Price: $0.28

PIII

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.7%), weak momentum, RSI 32

RSI (14): 32.3 · Price: $3.38

Fundamentals Snapshot

Metric NIVF PIII
Market Cap — —
Forward P/E 0.0 -0.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.0%
Operating Margin -1.8% 0.1%
EPS -34064.71 -33.02
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PIII is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.